imaging agent: in vivo kinetics and biodistribution studies in normal human subjects.
J NucÃ-Med I989;30:599-604.
14. Baldwin RM. lofetamine HCI 1-123(IMP). In: Weber DA, Devous MD Sr., Tikofsky
RS, Woodhead AD. Vivirito KJ. eds. Brain SPECT perfusion imaging: image
actfuisiiion. processing, display, and interpretation, CONF-9110368. Brookhaven
National Laboratory, United States Department of Energy; 1992:1-7.
15. Steinling M, Mazingue A, Rousscaux M, et al. Computerized tomography of the
distribution of N-isopropyl-p-123 iodoamphetaminc in cerebrovascular pathology.
Comparison with studies using the 133-xenon inhalation method. Ac/a Neural Belg
1987:87:113-124.
16. Weber DA. Franceschi D. Ivanovic M. et al. SPECT and planar brain imaging in crack
abuse: iodine-123-iodoamphelamine uptake and localization. J NucÃ-Med 1993:34:
899-907.
17. Volkow ND. Mullani N. Gould LK. Adler SS. Galley SJ. Sensitivity of measurements
of regional brain activation with oxygen-15-water and PET to time of stimulation and
period of image reconstruction. J NucÃ-Med 1991:32:58-61.
18. Mintun MA. Raichlc ME, Martin WR. Herscovitch P. Brain oxygen utilization
measured with O-15 radiotracers and positron emission tomography. J NucÃ-Med
1984:25:177-187.
19. Shishido F, Uemura K. Inugami A. Nagata K. Mirata Y. Measurement of cerebral
cirulation and metabolism in patients with spinoccrebellar degeneration using positron
emission tomography and O-I5 steady-state method. Kaku Igaku 1988:25:633-638.
20. Brihaye C. Depresseux JC. Comar D. Radiation dosimctry for bolus administration of
oxygen- 15-water. J NucÃ-Med 1995:36:651-656.
21. Smith T, Tong C, Lammertsma AA, et al. Dosimetry of intravenously administered
oxygcn-15 labelled water in man. a model based on experimental human data from 21
subjects. Eur J NucÃ-Med 1994;2I:l 126-1134.
22. Kearfott KJ. Absorbed dose estimates for positron emission tomography (PET): C"O,
"CO, and CO"O. J NucÃ-Med 1982:23:1031-1037.
23. Narayan S, Hichwa RD, Boles Ponto LL, Ponto JA, Watkins GL. Dosimetry of [I5O]
water: a physiologic approach. Med Phys 1996:23:159-168.
24. Tran Dinh YR. Hie O, Guichard JP. Haguenau M. Seylaz J. Cerebral postischemic
hyperfusion assessed by xenon-133 SPECT. J NucÃ-Med 1997:38:602-607.
25. Kaplan WD. Takvorian T. Morris JH. Rumbaugh CL. Connolly BT. Atkins HL.
Thallium-201 brain tumor imaging: a comparative study with pathologic correlation.
J NucÃ-Med 1987:28:47-52.
26. Kim KT. Black KL. Marciano D. et al. Thallium-201 SPECT imaging of brain tumors:
methods and results. J NucÃ-Med 1990:31:965-%9.
27. Kline JL, Noto RB. Glantz M. Single-photon emission CT in the evaluation of
recurrent brain tumor in patients treated with gamma knife radiosurgery or conven
tional radiation therapy. Am J Neurorudiol 1996:17:1681-1686.
28. Park CH, Sataloff R. Richard M. Zhang J. Kim SM. Tc-99m MIBI brain SPECT of
ccrebcllopontine angle tumors. Clin NucÃ-Med 1996:21:375-378.
29. O'Tuama LA. Packard AB. TrÃavesST. SPECT imaging of pediatrie brain tumor with
hexakis (methoxyisobutylisonitrile) technetium (I). J NucÃ-Med 1990:31:2040-2041.
30. Barth A, Haldemann AR. Reubi JC. et al. Noninvasivc differentiation of meningiomas
from other brain tumours using combined 11l-indium-octreotide 99m-technetiumDTPA brain scintigraphy. Acta Neurochir 1996:138:1179-1185.
31. Rollo FD. Cavalieri RR. Born M. Blei L, Chew M. Comparative evaluation of Wn'Tc
GH, TcO4, and "Te DTPA as brain imaging agents. Radiology 1997:123:379-
